Indirect Calorimeter Based Study in Patients With Liver Cirrhosis
METALIC
Metabolic and Clinical Effects of Enteral Nutrition Therapy: Measured Versus Estimated Energy and Substrate Requirements in Critically Ill Cirrhotics-A Randomized Controlled Trial
1 other identifier
interventional
83
1 country
1
Brief Summary
Part I- Observational study In the first part , investigator would investigate and compare the energy requirements and substrate utilization in healthy subjects and in patients with liver cirrhosis of various etiologies across the disease severity state viz compensated, stable decompensated, critically ill cirrhotics. The investigator would also enroll patients with chronic kidney disease, critically ill patients of acute liver failure or acute on chronic liver failure as disease controls. Part II- Randomized Controlled Study All the eligible, critically ill cirrhotic patients on mechanical ventilator support would be randomized to a control group (receiving the nutritional therapy as per the standard enteral nutritional practice in a critical care setting) or the intervention group (receiving enteral nutrition based on proposed measured requirements by Indirect calorimetry (IC) given till the patient is in ICU(Intensive care unit). The IC would be done thrice a week in both groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 26, 2019
CompletedFirst Posted
Study publicly available on registry
March 12, 2019
CompletedStudy Start
First participant enrolled
March 12, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2022
CompletedOctober 24, 2022
September 1, 2022
3.5 years
February 26, 2019
October 21, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Part 1: An Observational study
Study groups : 1. Healthy controls 2. Disease Groups * Patients with liver cirrhosis (compensated and decompensated) * Critically ill cirrhotics on mechanical ventilator support * patients with chronic kidney disease (CKD) (stable,non dialyzed, non oliguric outpatients) * Critically ill patients with Acute liver failure (ALF) on mechanical ventilator support * Critically ill patients with Acute on chronic liver failure(ACLF) on mechanical ventilator support * Severe acute pancreatitis on mechanical ventilator support Comparison of the prevalence of hyper and hypo metabolism in patients with chronic liver disease(CLD) and healthy controls and other disease groups.
One day (Observational)
Part 2: A Randomized controlled trial
Study group:Critically ill Cirrhotic: Diagnosed cases of liver cirrhosis with 2 or more organ failures (liver + renal/circulatory or respiratory failures) requiring ICU admission and on mechanical ventilator support meeting inclusion and exclusion criteria The difference in the duration of mechanical ventilation in critically ill ventilated patients with liver cirrhosis when the nutritional therapy delivered as per estimated energy requirements versus measured requirements
From date of enrollment until the date of ICU discharge /Leaving against medical advice, date of death from any cause, or off ventilatory support whichever comes first, assessed up to 28 days.
Secondary Outcomes (6)
Change in metabolic profile
The metabolic parameters would be assessed at the baseline, Day 7 and at Day 15 of enrollment
Change in inflammatory milieu
The inflammatory markers would be assessed at the baseline, Day 7 and at Day 15 of enrollment
Change in clinical parameters
The clinical parameters would be assessed daily from the date of enrollment until the date of ICU discharge, date of death from any cause, or out of mechanical ventilatory support whichever comes first, assessed up to 28 days.
Change in ventilatory and arterial blood gas parameters
The ventilatory and arterial blood gas parameters would be assessed daily from the date of enrollment until the date of ICU discharge, date of death from any cause, or out of mechanical ventilatory support whichever comes first, assessed up to 28 days.
Change in nutritional parameters
The nutritional parameters would be assesses at regular intervals maximum upto 28 days
- +1 more secondary outcomes
Study Arms (2)
Control arm
ACTIVE COMPARATORThis is the group of critically ill cirrhotic patients on mechanical ventilator support who would receive the nutritional therapy as per the standard enteral nutritional practice in a critical care setting in cirrhotics till the period admitted in ICU(Intensive care unit) 35-40 Kcal/Kg IBW/day; 1.5g protein per kg per day.
Intervention arm
EXPERIMENTALThis is the group of critically ill cirrhotic patients on mechanical ventilator support who would receive the nutritional therapy based on indirect calorimetry measurements till the period admitted in ICU(Intensive care unit); 1.5g protein per kg per day.
Interventions
Nutrition therapy based on measured energy expenditure by indirect calorimetry (IC) done alternate day till patient on ventilatory support and protein intake 1.5 g/kg IBW/day
Fixed standard nutritional therapy 35-40 Kcal/Kg IBW/day and 1.5 g protein /Kg IBW/Day till patient on ventilator
Eligibility Criteria
You may qualify if:
- Disease groups:
- Patients with liver cirrhosis (diagnosis established based on routine clinical, biochemical and at least radiological, endoscopic or histological parameters.) admitted in Liver coma Intensive care unit and those admitted in ward.
- Disease controls:
- Patients with Acute liver failure (diagnosis established based on routine clinical, biochemical and at least radiological parameters) admitted in Liver coma Intensive care unit
- Patients with severe acute pancreatitis (diagnosis established based on routine clinical, biochemical and at least radiological parameters) admitted in Liver coma Intensive care unit
- Healthy Controls:
- Healthy subjects- Relatives of patients with no known chronic diseases (Chronic obstructive pulmonary disease, Coronary artery disease, Type 2 diabetes, Hypertension, Hypothyroidism, Koch's disease) or not on any long term medications.
- Patients with liver cirrhosis (diagnosis established based on routine clinical, biochemical and at least radiological, endoscopic or histological parameters.) admitted in Liver coma Intensive care unit who require mechanical ventilation
You may not qualify if:
- Age\<18 years
- Active upper gastrointestinal bleeding
- If there are conditions which precluded IC, such as an FiO2 \>60 %, failure to cooperate, agitation, seizure activity, spasticity, or positive end-expiratory pressure (PEEP) \>10 mmHg.
- Pregnant women
- Refused to consent/ inability to obtain informed consent.
- Known long standing diabetic
- If there is any evidence of medical/surgical instability
- Hepatocellular carcinoma Extrahepatic malignancies
- With persistent gastrointestinal dysfunction and ileus
- Patients who would be readmitted to the ICU
- Known long standing diabetic
- Terminally ill patients on high inotropic support
- Acute liver failure
- If there is any evidence of medical/surgical instability
- If patients are taking any portion of nutrition by mouth.
- +7 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
ILBS
New Delhi, National Capital Territory of Delhi, 110070, India
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jaya Benjamin, Msc,PhD
Institute of Liver and Biliary Sciences, sector D-1, Vasantkunj, New Delhi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2019
First Posted
March 12, 2019
Study Start
March 12, 2019
Primary Completion
August 31, 2022
Study Completion
August 31, 2022
Last Updated
October 24, 2022
Record last verified: 2022-09